SCHEMBL19425501

SCHEMBL19425501

O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C/C=C/C2=CC=CC2)SC1=S

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DUSP3 P51452 1/20 0.72
▸ MAPT P10636 11/20 0.65
▸ MEN1 O00255 7/20 0.65
▸ KMT2A Q03164 7/20 0.65
▸ ALDH1A1 P00352 6/20 0.65
▸ POLB P06746 5/20 0.65
▸ L3MBTL1 Q9Y468 3/20 0.65
▸ RECQL P46063 3/20 0.65
▸ KDM4E B2RXH2 2/20 0.65
▸ USP2 O75604 2/20 0.65
▸ THRB P10828 2/20 0.65
▸ PSMD14 O00487 1/20 0.65
▸ MMP2 P08253 1/20 0.65
▸ BLM P54132 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.65
▸ PLA2G1B P04054 1/20 0.57
▸ ATG4B Q9Y4P1 1/20 0.57
▸ BCL2 P10415 5/20 0.55
▸ BCL2L2 Q92843 5/20 0.55
▸ BAD Q92934 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13894970 0.80 DUSP3 (0.71) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL14680220 0.79 MAPT (1.00) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL19425506 0.79 DUSP3 (0.71) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL19430434 0.75 MAPT (1.00) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL18598497 0.74 DUSP3 (0.64) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL20272271 0.73 MAPT (0.56) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL4568729 0.73 MAPT (0.80) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL2683718 0.73 MAPT (0.80) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL2683719 0.73 MAPT (0.80) DUSP3MAPTMEN1KMT2AALDH1A1
SCHEMBL13846498 0.72 MAPT (0.87) MAPTMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES TP53, NQO1, SHMT2 DUSP3 351/4885MAPT 1762/4885MEN1 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback